Tyrosine kinase inhibitors induce alternative spliced BCR-ABLIns35bp variant via inhibition of RNA polymerase II on genomic BCR-ABL.
Yuda J, Odawara J, Minami M, Muta T, Kohno K, Tanimoto K, Eto T, Shima T, Kikushige Y, Kato K, Takenaka K, Iwasaki H, Minami Y, Ohkawa Y, Akashi K, Miyamoto T.
Yuda J, et al.
Cancer Sci. 2020 Jul;111(7):2361-2373. doi: 10.1111/cas.14424. Epub 2020 Jun 14.
Cancer Sci. 2020.
PMID: 32314454
Free PMC article.